IBM, Affymetrix Target Diagnostics
Affymetrix expects to provide its genotyping platform, while IBM will offer systems integration and regulatory compliance services. This will allow companies to quickly assemble a lab built for genetic and genomic profiling as well as within regulatory requirements. Systems will cost in the range of $1 million to $2 million; a high-end system could process 100,000 arrays a year.
Next, the two companies expect to set their sights on using clinical genomics to improve trial design.
Read the full story at Bio-IT World